ReleaseWire Connect

An investor, who purchased shares of Arrowhead Research Corp (NASDAQ:ARWR), filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Arrowhead Research in connection with certain allegedly false and misleading statements made between August 12, 2014 and October 8, 2014.

An investigation on behalf of investors, who currently hold shares of Penford Corporation (NASDAQ:PENX), was announced concerning whether the takeover of Penford Corporation. by Ingredion Incorporated is unfair to NASDAQ:PENX stockholders.

An investigation on behalf of current long-term investors in shares of ITT Educational Services, Inc. (NYSE:ESI) concerning potential breaches of fiduciary duties by certain directors and officers of ITT Educational Services, Inc. was announced.

An investigation on behalf of investors, who currently hold shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), was announced concerning whether the takeover of Auxilium Pharmaceuticals, Inc. by Endo International plc for $33.25 per share is unfair to NASDAQ:AUXL stockholders.

An investigation on behalf of investors, who currently hold shares of Angie’s List Inc (NASDAQ:ANGI), was announced concerning whether a potential takeover of Angie’s List Inc would be unfair to NASDAQ:ANGI stockholders.

An investigation on behalf of current long-term investors in shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) concerning potential breaches of fiduciary duties by certain directors and officers of AcelRx Pharmaceuticals was announced.

An investigation on behalf of investors of Globalstar, Inc. (NYSEMKT:GSAT) shares over potential securities laws violations in connection certain financial statements was announced.

An investigation on behalf of current long-term investors in shares of Education Management Corp (NASDAQ:EDMC) concerning potential breaches of fiduciary duties by certain directors and officers of Education Management Corp was announced.

An investor, who currently holds shares of Ambit Biosciences Corp (NASDAQ:AMBI), filed a lawsuit in effort to halt the proposed takeover of Ambit Biosciences Corp. by Daiichi Sankyo Company for $15 per share.

A deadline is coming up on November 17, 2014 in the lawsuit filed for investors of Bankrate Inc (NYSE:RATE) over alleged securities laws violations by Bankrate Inc.